To study the involvement of tumor expressed Nidogen-1 in neutrophil cytotoxicity, we used specific shRNA to knock down the expression of Nidogen-1 and Hspg2 in AT3 and LLC cells (Figure 6A,B). Here, NID1 is linked to neoplasm.